| 000 | 01570 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250514055645.0 | ||
| 264 | 0 | _c20030924 | |
| 008 | 200309s 0 0 eng d | ||
| 022 | _a0964-6906 | ||
| 024 | 7 |
_a10.1093/hmg/ddg015 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWolvetang, E J | |
| 245 | 0 | 0 |
_aETS2 overexpression in transgenic models and in Down syndrome predisposes to apoptosis via the p53 pathway. _h[electronic resource] |
| 260 |
_bHuman molecular genetics _cFeb 2003 |
||
| 300 |
_a247-55 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aApoptosis _xgenetics |
| 650 | 0 | 4 | _aDNA-Binding Proteins |
| 650 | 0 | 4 |
_aDown Syndrome _xmetabolism |
| 650 | 0 | 4 |
_aGene Expression Regulation _xgenetics |
| 650 | 0 | 4 | _aHeLa Cells |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Transgenic |
| 650 | 0 | 4 | _aProto-Oncogene Protein c-ets-2 |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins _xbiosynthesis |
| 650 | 0 | 4 | _aRepressor Proteins |
| 650 | 0 | 4 |
_aThymus Gland _xpathology |
| 650 | 0 | 4 |
_aTrans-Activators _xbiosynthesis |
| 650 | 0 | 4 | _aTranscription Factors |
| 650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xgenetics |
| 700 | 1 | _aWilson, T J | |
| 700 | 1 | _aSanij, E | |
| 700 | 1 | _aBusciglio, J | |
| 700 | 1 | _aHatzistavrou, T | |
| 700 | 1 | _aSeth, A | |
| 700 | 1 | _aHertzog, P J | |
| 700 | 1 | _aKola, I | |
| 773 | 0 |
_tHuman molecular genetics _gvol. 12 _gno. 3 _gp. 247-55 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/hmg/ddg015 _zAvailable from publisher's website |
| 999 |
_c12353958 _d12353958 |
||